298 related articles for article (PubMed ID: 21509684)
1. Imaging in multiple myeloma.
Delorme S; Baur-Melnyk A
Recent Results Cancer Res; 2011; 183():133-47. PubMed ID: 21509684
[TBL] [Abstract][Full Text] [Related]
2. Imaging in multiple myeloma.
Delorme S; Baur-Melnyk A
Eur J Radiol; 2009 Jun; 70(3):401-8. PubMed ID: 19272726
[TBL] [Abstract][Full Text] [Related]
3. ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
Dammacco F; Rubini G; Ferrari C; Vacca A; Racanelli V
Clin Exp Med; 2015 Feb; 15(1):1-18. PubMed ID: 25218739
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone.
Nanni C; Rubello D; Zamagni E; Castellucci P; Ambrosini V; Montini G; Cavo M; Lodi F; Pettinato C; Grassetto G; Franchi R; Gross MD; Fanti S
In Vivo; 2008; 22(4):513-7. PubMed ID: 18712181
[TBL] [Abstract][Full Text] [Related]
6. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
[TBL] [Abstract][Full Text] [Related]
7. FDG-PET in the evaluation of myeloma in 2012.
Bodet-Milin C; Eugène T; Bailly C; Lacombe M; Frampas E; Dupas B; Moreau P; Kraeber-Bodéré F
Diagn Interv Imaging; 2013 Feb; 94(2):184-9. PubMed ID: 23287424
[TBL] [Abstract][Full Text] [Related]
8. Comparison of (11)C-4'-thiothymidine, (11)C-methionine, and (18)F-FDG PET/CT for the detection of active lesions of multiple myeloma.
Okasaki M; Kubota K; Minamimoto R; Miyata Y; Morooka M; Ito K; Ishiwata K; Toyohara J; Inoue T; Hirai R; Hagiwara S; Miwa A
Ann Nucl Med; 2015 Apr; 29(3):224-32. PubMed ID: 25421383
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin D-lambda type multiple myeloma presenting with FDG-PET/CT negative bone marrow involvement.
Machida H; Shinohara T; Hino H; Yoshida M; Hatakeyama N; Okano Y; Inayama M; Hosokawa E; Abe S; Naruse K; Iwahara Y; Ogushi F
Intern Med; 2011; 50(14):1483-7. PubMed ID: 21757834
[TBL] [Abstract][Full Text] [Related]
11. Multiple myeloma: 18F-FDG-PET/CT and diagnostic imaging.
Mihailovic J; Goldsmith SJ
Semin Nucl Med; 2015 Jan; 45(1):16-31. PubMed ID: 25475376
[TBL] [Abstract][Full Text] [Related]
12. Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT.
Hanrahan CJ; Christensen CR; Crim JR
Radiographics; 2010 Jan; 30(1):127-42. PubMed ID: 20083590
[TBL] [Abstract][Full Text] [Related]
13. State-of-the-art of bone marrow imaging in multiple myeloma.
Martí-Bonmatí L; Ramirez-Fuentes C; Alberich-Bayarri Á; Ruiz-Llorca C
Curr Opin Oncol; 2015 Nov; 27(6):540-50. PubMed ID: 26352540
[TBL] [Abstract][Full Text] [Related]
14. State of the art imaging of multiple myeloma: comparative review of FDG PET/CT imaging in various clinical settings.
Mesguich C; Fardanesh R; Tanenbaum L; Chari A; Jagannath S; Kostakoglu L
Eur J Radiol; 2014 Dec; 83(12):2203-2223. PubMed ID: 25308249
[TBL] [Abstract][Full Text] [Related]
15. F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma.
Ak I; Gulbas Z
Ann Hematol; 2011 Jan; 90(1):81-7. PubMed ID: 20690019
[TBL] [Abstract][Full Text] [Related]
16. Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma.
Lütje S; de Rooy JW; Croockewit S; Koedam E; Oyen WJ; Raymakers RA
Ann Hematol; 2009 Dec; 88(12):1161-8. PubMed ID: 19763570
[TBL] [Abstract][Full Text] [Related]
17. Value of FDG PET in the assessment of patients with multiple myeloma.
Bredella MA; Steinbach L; Caputo G; Segall G; Hawkins R
AJR Am J Roentgenol; 2005 Apr; 184(4):1199-204. PubMed ID: 15788594
[TBL] [Abstract][Full Text] [Related]
18. Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI.
Zambello R; Crimì F; Lico A; Barilà G; Branca A; Guolo A; Varin C; Vezzaro R; Checuz L; Scapin V; Berno T; Pizzi M; Ponzoni A; De Biasi E; Vio S; Semenzato G; Zucchetta P; Lacognata C
Ann Hematol; 2019 Mar; 98(3):679-689. PubMed ID: 30539276
[TBL] [Abstract][Full Text] [Related]
19. F-18 FDG PET/CT staging of multiple myeloma with diffuse osseous and extramedullary lesions.
Wiesenthal AA; Nguyen BD
Clin Nucl Med; 2007 Oct; 32(10):797-801. PubMed ID: 17885362
[TBL] [Abstract][Full Text] [Related]
20. [Staging of multiple myeloma with MRI: comparison to MSCT and conventional radiography].
Baur-Melnyk A; Reiser M
Radiologe; 2004 Sep; 44(9):874-81. PubMed ID: 15365631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]